Who is impacted? Every day, countless veterans and women who have experienced trauma face the overwhelming challenge of post-traumatic stress disorder (PTSD). Traditional treatments often fall short for these individuals, leaving them with persistent symptoms and limited options. The Compassionate Use and Research of Entheogens (CURE) Act offers a groundbreaking alternative by providing access to regulated, science-driven psychedelic-assisted therapy, which has shown significant promise in treating severe PTSD more effectively than conventional methods.

What is at stake? The stakes are high. If we fail to act, those suffering from PTSD may continue to struggle with inadequate solutions, potentially leading to increased rates of depression, anxiety, substance abuse and misuse, and suicide. Conversely, implementing the CURE Act could transform lives by offering new, effective therapeutic options under a safe and legal framework. This legislation is not about endorsing recreational drug use but about providing supervised, medical access to psilocybin therapies, which have been recognized by the FDA as a “breakthrough treatment.”

Why is now the time to act? There has never been a more critical time to address our mental health crisis. With models in Oregon and Colorado and international precedents in Australia, the momentum for change is building. The CURE Act represents a timely opportunity to align with global shifts toward accessible, innovative therapies that prioritize patient safety and public health. By supporting this Act, you are not only championing progressive mental health solutions but also directly contributing to the well-being of our veterans and women most in need.

For more detailed information on the CURE Act and its benefits for those with PTSD, please visit www.illinoispsychedelic.org/cureact.

Your leadership in co-sponsoring and supporting the CURE Act can truly make a difference. Thank you for considering this urgent and transformative initiative.